DIFFERENTIATING ASPECTS OF OPIOID RECEPTOR-BINDING BY [H-3](-) (1R,5R,9R,2''S)-5,9-DIMETHYL-2-TETRAHYDROFURYL-2'-HYDROXY-6,7-BENZOMORPHAN HYDROCHLORIDE ([H-3]MR-2034), A DRUG PREFERENTIALLY ACTING ON CHI-RECEPTORS

被引：0

|

作者：

ENSINGER, HA

机构：

来源：

ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 1985年 / 35卷 / 1A期

关键词：

D O I：

暂无

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

收藏

页码：447 / 451

页数：5

相关论文

共 19 条

[1] STRUCTURAL STUDIES OF SUBSTITUTED 6,7-BENZOMORPHAN COMPOUNDS .6. (-)-(1R,5R,9R,13R)-2'-HYDROXY-5,9ALPHA-DIMETHYL-2-(TETRAHYDROFURFURYL)-6,7-BENZOMORPHAN AND (-)-(1R,5R,9R,13S)-2'-HYDROXY-5,9-DIMETHYL-2-(TETRAHYDROFURFURYL)-6,7-BENZOMORPHAN TARTRATE MONOHYDRATE
PEETERS, OM
DERANTER, CJ
BLATON, NM
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 1982, 38 (DEC): : 3055 - 3059
[2] STRUCTURAL STUDIES OF SUBSTITUTED 6,7-BENZOMORPHAN COMPOUNDS .9. (-)-(1R,5R,9R)-2-ETHOXYETHYL-2'-HYDROXY-5,9-DIMETHYL-6,7-BENZOMORPHAN HYDROBROMIDE
VERLINDE, CL
BLATON, NM
PEETERS, OM
DERANTER, CJ
ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1988, 44 : 1789 - 1791
[3] STRUCTURAL STUDIES OF SUBSTITUTED 6,7-BENZOMORPHAN COMPOUNDS .11. (-)-(1R,5R,9R)-2'-HYDROXY-2-(3-METHOXYPROPYL)-5,9-DIMETHYL-6,7-BENZOMORPHAN HYDROBROMIDE MONOHYDRATE
VERLINDE, CL
BLATON, NM
PEETERS, OM
DERANTER, CJ
ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1988, 44 : 1609 - 1611
[4] STRUCTURAL STUDIES OF SUBSTITUTED 6,7-BENZOMORPHAN COMPOUNDS .16. STRUCTURE OF THE OPIOID KAPPA-AGONIST (-)-(1R,5R,9R,2''S)-2'-HYDROXY-2-(2-METHOXYPROPYL)-5,9-DIMETHYL-6,7-BENZOMORPHAN HYDROBROMIDE(I) AND ITS INACTIVE (-)-(1R,5R,9R,2''R) DIASTEREOMER(II)
VERLINDE, CL
PEETERS, OM
BLATON, NM
DERANTER, CJ
ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1990, 46 : 663 - 666
[5] STRUCTURAL STUDIES OF SUBSTITUTED 6,7-BENZOMORPHAN COMPOUNDS .15. STRUCTURE AND CONFORMATIONAL-ANALYSIS OF THE OPIOID ANTAGONIST (-)-(1R,5R,9R)-5,9-DIETHYL-2-(3-FURYLMETHYL)-2'-HYDROXY-6,7-BENZOMORPHAN (MR2266)
VERLINDE, CL
BLATON, NM
PEETERS, OM
DERANTER, CJ
ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1989, 45 : 1797 - 1802
[6] STRUCTURAL STUDIES OF SUBSTITUTED 6,7-BENZOMORPHAN COMPOUNDS .12. (-)-(1R,5R,9R,2''R)-2'-HYDROXY-5,9-DIMETHYL-2-[2-(TETRAHYDRO-2-FURYL)ETHYL]-6,7-BENZOMORPHAN HYDROBROMIDE
VERLINDE, CL
BLATON, NM
PEETERS, OM
DERANTER, CJ
ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1988, 44 : 1611 - 1614
[7] Pharmacological studies with a nonpeptidic, delta-opioid (-)-(1R,5R,9R)-5, 9-dimethyl-2′-hydroxy-2-(6-hydroxyhexyl)-6,7-benzomorphan hydrochloride ((-)-NIH 11082)
Aceto, Mario D.
May, Everette L.
Harris, Louis S.
Bowman, Edward R.
Cook, Charles D.
EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 566 (1-3) : 88 - 93
[8] STRUCTURAL STUDIES OF SUBSTITUTED 6,7-BENZOMORPHAN COMPOUNDS .10. (-)-(1R,5R,9R)-2'-HYDROXY-2-METHOXYETHYL-5,9-DIMETHYL-6,7-BENZOMORPHANHYDROBROMIDE MONOHYDRATE
VERLINDE, CL
BLATON, NM
PEETERS, OM
DERANTER, CJ
ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1988, 44 : 1792 - 1794
[9] Synthesis and in vitro and in vivo activity of (-)-(1R,5R,9R)- and (+)-(1S,5S,9S)-N-alkenyl-, -N-alkynyl-, and -N-cyanoalkyl-5,9-dimethyl-2′-hydroxy-6,7-benzomorphan homologues
May, EL
Jacobson, AE
Mattson, MV
Traynor, JR
Woods, JH
Harris, LS
Bowman, ER
Aceto, MD
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (26) : 5030 - 5036
[10] STRUCTURAL STUDIES OF SUBSTITUTED 6,7-BENZOMORPHAN COMPOUNDS .7. (1S,5R,9R)-2-CYCLOPROPYLMETHYL-2'-HYDROXY-5,9-DIMETHYL-8-OXO-6,7-BENZOMORPHAN HYDROCHLORIDE MONOHYDRATE (KETAZOCINE), C18H23NO2.HCL.H2O
VERLINDE, CL
DERANTER, CJ
ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1983, 39 (DEC) : 1703 - 1706